{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:13:38Z","timestamp":1776701618122,"version":"3.51.2"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jconrel.2021.11.039","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T12:51:17Z","timestamp":1638190277000},"page":"457-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH"],"prefix":"10.1016","volume":"341","author":[{"given":"Hitoshi","family":"Maeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Saruwatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Minayoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Ichimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisei","family":"Nagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Taura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Oniki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Wakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Shuto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Iwakiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Otagiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.11.039_bb0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/hep.29724","article-title":"Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0010","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0015","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0025","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0030","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2017.10.015","article-title":"Pharmacotherapy for NASH: current and emerging","volume":"68","author":"Konerman","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0035","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2009.03.008","article-title":"Kupffer cells in non-alcoholic fatty liver disease: the emerging view","volume":"51","author":"Baffy","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0045","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jhep.2010.04.037","article-title":"Characterization of two F4\/80-positive Kupffer cell subsets by their function and phenotype in mice","volume":"53","author":"Kinoshita","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1440-1746.2006.04758.x","article-title":"Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients","volume":"22","author":"Park","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0055","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0060","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/gutjnl-2011-300269","article-title":"Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice","volume":"61","author":"Ye","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.it.2004.12.001","article-title":"The mannose receptor: linking homeostasis and immunity through sugar recognition","volume":"26","author":"Taylor","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0070","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3892\/ijo.2015.3120","article-title":"The collagen receptor uPARAP\/Endo180 in tissue degradation and cancer (review)","volume":"47","author":"Melander","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0075","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.tibs.2015.03.013","article-title":"The glycobiology of the CD system: a dictionary for translating marker designations into glycan\/lectin structure and function","volume":"40","author":"Gabius","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0080","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1074\/jbc.M513277200","article-title":"Structural model for the mannose receptor family uncovered by electron microscopy of Endo180 and the mannose receptor","volume":"281","author":"Boskovic","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2014.03.013","article-title":"A clinical update of using albumin as a drug vehicle - a commentary","volume":"190","author":"Kratz","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0090","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1080\/17425247.2016.1193149","article-title":"Albumin nanostructures as advanced drug delivery systems","volume":"13","author":"Karimi","year":"2016","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1124\/jpet.114.219493","article-title":"Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+\/CD206+ Kupffer cell-targeted nanoantioxidant for treatment of two acute hepatitis models","volume":"352","author":"Maeda","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2010.03.010","article-title":"Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics","volume":"145","author":"Hirata","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1248\/bpb.b19-00599","article-title":"Repeated administration of Kupffer cells-targeting nanoantioxidant ameliorates liver fibrosis in an experimental mouse model","volume":"43","author":"Maeda","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0110","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1111\/bph.14383","article-title":"A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway","volume":"175","author":"Bao","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112496","article-title":"A novel long-acting oxyntomodulin analogue eliminates diabetes and obesity in mice","volume":"203","author":"Ma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.01.008","article-title":"Intravenous sustained-release nifedipine ameliorates nonalcoholic fatty liver disease by restoring autophagic clearance","volume":"197","author":"Lee","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0125","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1021\/acs.molpharmaceut.8b00548","article-title":"Polyurethane nanoparticle-loaded fenofibrate exerts inhibitory effects on nonalcoholic fatty liver disease in mice","volume":"15","author":"Cao","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/21691401.2018.1453830","article-title":"Targeted delivery of microRNA 146b mimic to hepatocytes by lactosylated PDMAEMA nanoparticles for the treatment of NAFLD","volume":"46","author":"He","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0135","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.1021\/acsnano.0c01007","article-title":"Targeted delivery of notch inhibitor attenuates obesity-induced glucose intolerance and liver fibrosis","volume":"14","author":"Richter","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hep.20302","article-title":"Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice","volume":"40","author":"McCuskey","year":"2004","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2021.11.039_bb0145","first-page":"S7","article-title":"Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis-comparison with liver cirrhosis related to hepatitis C virus and nonalcoholic steatohepatitis","volume":"34","author":"Takahashi","year":"2010","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0150","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd4623","article-title":"Strategies to increase nitric oxide signalling in cardiovascular disease","volume":"14","author":"Lundberg","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0155","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic steatohepatitis clinical research, design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0160","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0165","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","author":"Leclercq","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0170","article-title":"A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis","volume":"4","author":"Ejima","year":"2016","journal-title":"Phys. Rep."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0175","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1073\/pnas.0406075101","article-title":"Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo","volume":"101","author":"Janero","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0180","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.xphs.2017.10.023","article-title":"Dual therapeutic effects of an albumin-based nitric oxide donor on 2 experimental models of chronic kidney disease","volume":"107","author":"Oshiro","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0185","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/10717544.2018.1464083","article-title":"Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions","volume":"25","author":"Minayoshi","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0190","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1158\/0008-5472.CAN-06-3496","article-title":"The collagen receptor Endo180 (CD280) is expressed on basal-like breast tumor cells and promotes tumor growth in vivo","volume":"67","author":"Wienke","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0195","doi-asserted-by":"crossref","first-page":"D1284","DOI":"10.1093\/nar\/gkx1188","article-title":"JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework","volume":"46","author":"Khan","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mvr.2005.08.001","article-title":"The role of nitric oxide in the modulation of hepatic microcirculation and tissue oxygenation in an experimental model of hepatic steatosis","volume":"70","author":"Ijaz","year":"2005","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0205","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00109-012-0880-5","article-title":"Nitric oxide signaling in hypoxia","volume":"90","author":"Ho","year":"2012","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0210","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1593\/neo.08734","article-title":"Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer","volume":"11","author":"Buchler","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0215","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1083\/jcb.200302124","article-title":"GPI-anchored uPAR requires Endo180 for rapid directional sensing during chemotaxis","volume":"162","author":"Sturge","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0220","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/mol.108.045278","article-title":"Nitric oxide donor, (+\/\u2212)-S-nitroso-N-acetylpenicillamine, stabilizes transactive hypoxia-inducible factor-1alpha by inhibiting von Hippel-Lindau recruitment and asparagine hydroxylation","volume":"74","author":"Park","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0225","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1074\/jbc.M308197200","article-title":"Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling","volume":"279","author":"Kasuno","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0230","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/j.2040-4603.2013.tb00529.x","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0235","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1179\/1351000213Y.0000000050","article-title":"The relationship between oxidative stress and nonalcoholic fatty liver disease: its effects on the development of nonalcoholic steatohepatitis","volume":"18","author":"Ucar","year":"2013","journal-title":"Redox Rep."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0240","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbrc.2015.06.121","article-title":"Oxidative stress triggers lipid droplet accumulation in primary cultured hepatocytes by activating fatty acid synthesis","volume":"464","author":"Lee","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0245","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0250","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease","volume":"58","author":"Leung","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0255","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver--from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0260","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2018.03.001","article-title":"Macrophage-targeted therapeutics for metabolic disease","volume":"39","author":"Peterson","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0265","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0270","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fendo.2018.00485","article-title":"Pathogenesis of nonalcoholic steatohepatitis and hormone-based therapeutic approaches","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0275","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.3389\/fimmu.2019.02893","article-title":"Macrophage function in the pathogenesis of non-alcoholic fatty liver disease: the mac attack","volume":"10","author":"Oates","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0280","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.phymed.2016.12.006","article-title":"Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor","volume":"25","author":"Duan","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0285","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3892\/ijmm.2012.1029","article-title":"Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells","volume":"30","author":"Kim","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0290","article-title":"Aliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0295","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.7150\/ijbs.26086","article-title":"Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice","volume":"14","author":"Li","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0300","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41419-019-1994-2","article-title":"Progranulin attenuates liver fibrosis by downregulating the inflammatory response","volume":"10","author":"Yoo","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0305","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.dld.2019.09.002","article-title":"L-carnitine supplementation attenuates NAFLD progression and cardiac dysfunction in a mouse model fed with methionine and choline-deficient diet","volume":"52","author":"Mollica","year":"2020","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0310","first-page":"2683","article-title":"Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice","volume":"6","author":"Itagaki","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0315","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jhep.2008.03.026","article-title":"MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes","volume":"49","author":"Larter","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0320","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"Rinella","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0325","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","author":"Rinella","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0330","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/hep.22561","article-title":"Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice","volume":"48","author":"Nakashima","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0335","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/hep.23267","article-title":"Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine","volume":"51","author":"Saito","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0340","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/07315724.2008.10719703","article-title":"Prevention and reversion of nonalcoholic steatohepatitis in OB\/OB mice by S-nitroso-N-acetylcysteine treatment","volume":"27","author":"de Oliveira","year":"2008","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0345","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1021\/tx960037q","article-title":"Nitric oxide regulation of tissue free radical injury","volume":"9","author":"Rubbo","year":"1996","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0350","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0005-2728(99)00027-4","article-title":"Nitric oxide and lipid peroxidation","volume":"1411","author":"Hogg","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0355","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1073\/pnas.89.16.7674","article-title":"Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin","volume":"89","author":"Stamler","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0360","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/01.RES.0000117771.63140.D6","article-title":"Enhanced S-nitroso-albumin formation from inhaled NO during ischemia\/reperfusion","volume":"94","author":"Ng","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0365","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1021\/bm7011746","article-title":"S-nitrosothiol-modified dendrimers as nitric oxide delivery vehicles","volume":"9","author":"Stasko","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0370","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/21218","article-title":"Regulation of endothelium-derived nitric oxide production by the protein kinase Akt","volume":"399","author":"Fulton","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0375","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12876-017-0592-y","article-title":"Non alcoholic fatty liver disease and eNOS dysfunction in humans","volume":"17","author":"Persico","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0380","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/HYPERTENSIONAHA.119.13419","article-title":"Nonalcoholic fatty liver disease: an emerging driver of hypertension","volume":"75","author":"Zhao","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0385","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0390","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.biocel.2007.04.014","article-title":"Kinetics of uptake and deacetylation of N-acetylcysteine by human erythrocytes","volume":"39","author":"Raftos","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0395","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0400","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/919217","article-title":"Efficacy of the reactive oxygen species generated by immobilized TiO2 in the photocatalytic degradation of diclofenac","volume":"2015","author":"Di Credico","year":"2015","journal-title":"Int. J. Photoenerg."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0405","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/immu.200310024","article-title":"Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages","volume":"33","author":"Nguyen","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0410","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/glycob\/cwj077","article-title":"The carbohydrate-recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose","volume":"16","author":"McGreal","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0415","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.127.3301.756.b","article-title":"On the composition of zymosan","volume":"127","author":"Di Carlo","year":"1958","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0420","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.gt.3301089","article-title":"Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes","volume":"7","author":"Kawakami","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0425","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpharm.2004.08.021","article-title":"Uptake characteristics of mannosylated and fucosylated bovine serum albumin in primary cultured rat sinusoidal endothelial cells and Kupffer cells","volume":"287","author":"Higuchi","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0430","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0005-2736(01)00267-X","article-title":"Involvement of serum mannan binding proteins and mannose receptors in uptake of mannosylated liposomes by macrophages","volume":"1511","author":"Opanasopit","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0435","doi-asserted-by":"crossref","first-page":"2104136","DOI":"10.1002\/adfm.202104136","article-title":"A mannosylated, PEGylated albumin as a drug delivery system for the treatment of cancer stroma cells","volume":"31","author":"Mizuta","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0440","doi-asserted-by":"crossref","first-page":"1700403","DOI":"10.1002\/adfm.201700403","article-title":"Dual-targeting to cancer cells and M2 macrophages via biomimetic delivery of mannosylated albumin nanoparticles for drug-resistant cancer therapy","volume":"27","author":"Zhao","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0445","first-page":"L740","article-title":"Hypoxia-inducible factor-1\u03b1 mediates TGF-\u03b2-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis","volume":"300","author":"Ueno","year":"2011","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0450","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/00365520802433249","article-title":"Utility of quantitative 99mTc-phytate scintigraphy to diagnose early-stage non-alcoholic steatohepatitis","volume":"44","author":"Kikuchi","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0455","doi-asserted-by":"crossref","first-page":"32320","DOI":"10.1074\/jbc.M203631200","article-title":"The C-type lectin receptor Endo180 displays internalization and recycling properties distinct from other members of the mannose receptor family","volume":"277","author":"Howard","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0460","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fphys.2016.00017","article-title":"The role of NADPH oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts","volume":"7","author":"Liang","year":"2016","journal-title":"Front. Physiol."},{"issue":"Pt 6","key":"10.1016\/j.jconrel.2021.11.039_bb0465","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1242\/jcs.113.6.1021","article-title":"Endo180, an endocytic recycling glycoprotein related to the macrophage mannose receptor is expressed on fibroblasts, endothelial cells and macrophages and functions as a lectin receptor","volume":"113","author":"Sheikh","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0470","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.biomaterials.2017.03.011","article-title":"Long-term bioavailability of redox nanoparticles effectively reduces organ dysfunctions and death in whole-body irradiated mice","volume":"129","author":"Feliciano","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0475","doi-asserted-by":"crossref","first-page":"4984597","DOI":"10.1155\/2016\/4984597","article-title":"Redox nanoparticle therapeutics for acetaminophen-induced hepatotoxicity in mice","volume":"2016","author":"Boonruamkaew","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0480","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/toxsci\/kfl173","article-title":"Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis","volume":"96","author":"Roberts","year":"2007","journal-title":"Toxicol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2021.11.039_bb0485","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1440-1746.2010.06592.x","article-title":"Reactive oxygen and mechanisms of inflammatory liver injury: present concepts","volume":"26","author":"Jaeschke","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0490","series-title":"Disease and Mortality in Sub-Saharan Africa, Washington (DC)","article-title":"Lifestyle and related risk factors for chronic diseases","author":"Steyn","year":"2006"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0495","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cld.806","article-title":"Epidemiology of alcohol use and alcoholic liver disease","volume":"13","author":"Mellinger","year":"2019","journal-title":"Clin. Liver Dis. (Hoboken)"},{"key":"10.1016\/j.jconrel.2021.11.039_bb0500","doi-asserted-by":"crossref","first-page":"147","DOI":"10.35946\/arcr.v38.2.01","article-title":"Alcoholic liver disease: pathogenesis and current management","volume":"38","author":"Osna","year":"2017","journal-title":"Alcohol Res."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0505","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0510","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Astroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0515","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat. Rev. Dis. Prime."},{"key":"10.1016\/j.jconrel.2021.11.039_bb0520","doi-asserted-by":"crossref","first-page":"8393","DOI":"10.3748\/wjg.v20.i26.8393","article-title":"Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease","volume":"20","author":"Toshikuni","year":"2014","journal-title":"World J. Gastroenterol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921006349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921006349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:18:01Z","timestamp":1759162681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921006349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":104,"alternative-id":["S0168365921006349"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.039","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}